China Universal Asset Management Company’s CorMedix CRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$98K Sell
12,486
-1,496
-11% -$11.8K 0.01% 418
2026
Q1
$94.9K Buy
13,982
+1,143
+9% +$8.45K 0.01% 407
2025
Q4
$149K Sell
12,839
-246
-2% -$2.72K 0.01% 375
2025
Q3
$152K Sell
13,085
-537
-4% -$6.49K 0.01% 353
2025
Q2
$168K Buy
13,622
+1,451
+12% +$16K 0.02% 326
2025
Q1
$75K Sell
12,171
-695
-5% -$7.19K 0.01% 384
2024
Q4
$104K Buy
+12,866
New +$129K 0.01% 386

Other funds holding CRMD

China Universal Asset Management Company's CRMD Position: Q2 2026 in Review

China Universal Asset Management Company reduced its CorMedix (CRMD) stake by 11% in Q2 2026, selling an estimated $11.8K and leaving 12,486 shares worth $98K. The position accounts for 0.01% of the portfolio, ranked #418.

China Universal Asset Management Company first reported a position in CRMD in Q4 2024 and has held it in 7 quarters since. The position peaked at $168K in Q2 2025. 96 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • China Universal Asset Management Company held 12,486 shares of CorMedix worth $98K as of Q2 2026.
  • China Universal Asset Management Company sold 1,496 CorMedix shares in Q2 2026, an estimated $11.8K.
  • CorMedix made up 0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #418 holding.
  • China Universal Asset Management Company first reported a position in CorMedix in Q4 2024 and has held it in 7 quarters since.
  • China Universal Asset Management Company's CorMedix position peaked at $168K in Q2 2025.
  • 96 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.